<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35724687</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-4286</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme</Title><ISOAbbreviation>Horm Metab Res</ISOAbbreviation></Journal><ArticleTitle>Long-COVID, Metabolic and Endocrine Disease.</ArticleTitle><Pagination><StartPage>562</StartPage><EndPage>566</EndPage><MedlinePgn>562-566</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/a-1878-9307</ELocationID><Abstract><AbstractText>In the aftermath of the corona pandemic, long-COVID or post-acute COVID-19 syndrome still represents a great challenge, and this topic will continue to represent a significant health problem in the coming years. At present, the impact of long-COVID on our health system cannot be fully assessed but according to current studies, up to 40% of people who have been infected with SARS-CoV-2 suffer from clinically relevant symptoms of long-COVID syndrome several weeks to months after the acute phase. The main symptoms are chronic fatigue, dyspnea, and various cognitive symptoms. Initial studies have shown that people with overweight and diabetes mellitus have a higher risk of developing long-COVID associated symptoms. Furthermore, repeated treatment of acute COVID-19 and long-COVID with steroids can contribute to long-term metabolic and endocrine disorders. Therefore, a structured program with rehabilitation and physical activity as well as optimal dietary management is of utmost importance, especially for patients with metabolic diseases and/or long-COVID. Furthermore, the removal of autoantibodies and specific therapeutic apheresis procedures could lead to a significant improvement in the symptoms of long-COVID in individual patients.</AbstractText><CopyrightInformation>The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bornstein</LastName><ForeName>Stefan R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Medicine III, Universit&#xe4;tsklinikum Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences &amp; Medicine, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozma</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine III, Universit&#xe4;tsklinikum Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamel</LastName><ForeName>Margrit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Regenerative Therapies Dresden, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamad</LastName><ForeName>Mawieh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sharjah Institute for Medical Research, University of Sharjah College of Health Sciences, Sharjah, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammad</LastName><ForeName>Mohammad G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0002-6775-1955</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Naveed A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saber</LastName><ForeName>Maha M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-9287-7621</Identifier><AffiliationInfo><Affiliation>College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semreen</LastName><ForeName>Mohammad H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steenblock</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine III, Universit&#xe4;tsklinikum Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Deutsche Forschungsgemeinschaft</GrantID><Agency>288034826,314061271</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Horm Metab Res</MedlineTA><NlmUniqueID>0177722</NlmUniqueID><ISSNLinking>0018-5043</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004700" MajorTopicYN="Y">Endocrine System Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>20</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35724687</ArticleId><ArticleId IdType="pmc">PMC9363148</ArticleId><ArticleId IdType="doi">10.1055/a-1878-9307</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim Y, Bitna H, Kim S W et al.Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis. 2022;22:93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8793328</ArticleId><ArticleId IdType="pubmed">35086489</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman S N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4:e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J P, Chesney E, Oliver D et al.Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla A R, Ankermann T, Behrends U et al.[S1 guideline post-COVID/long-COVID] Pneumologie. 2021;75:869&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceravolo M G, Arienti C, de Sire A et al.Rehabilitation and COVID-19: the Cochrane rehabilitation 2020 rapid living systematic review. Eur J Phys Rehabil Med. 2020;56:642&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">32705860</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care
Excellence  Clinical guidelines. In: COVID-19 rapid guideline: managing the long-term
effects of COVID-19 London: National Institute for Health and Care Excellence (NICE). NIE; 2020. available at:https://www.ncbi.nlm.nih.gov/books/NBK567264/</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C H, Murray B, Varsavsky T et al.Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn K G, Brokstad K A et al.Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S R, Rubino F, Ludwig B et al.Consequences of the COVID-19 pandemic for patients with metabolic diseases. Nat Metab. 2021;3:289&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">33633407</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S R, Zimmet P, Rubino F et al.Management of diabetes in patients with COVID-19 &#x2013; Authors&#x2019; reply. Lancet Diabetes Endocrinol. 2020;8:669&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373385</ArticleId><ArticleId IdType="pubmed">32707113</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, Richter S, Berger I et al.Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun. 2021;12:3534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8192507</ArticleId><ArticleId IdType="pubmed">34112801</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, Schwarz PE H, Ludwig B et al.COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021;9:786&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8489878</ArticleId><ArticleId IdType="pubmed">34619105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Zhou L, Sun X et al.Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7:9110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567209</ArticleId><ArticleId IdType="pubmed">28831119</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino F, Amiel S A, Zimmet P et al.New-onset diabetes in Covid-19. N Engl J Med. 2020;383:789&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304415</ArticleId><ArticleId IdType="pubmed">32530585</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. Antiviral pills could change pandemic&#x2019;s course. Science. 2021;374:799&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">34762459</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikus G, Foerster K I, Terstegen T et al.Oral drugs against COVID-19-management of drug interactions with the use of nirmatrelvir/ritonavir. Dtsch Arztebl Int. 2022 doi: 10.3238/arztebl.m2022.0152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0152</ArticleId><ArticleId IdType="pmc">PMC9400198</ArticleId><ArticleId IdType="pubmed">35302484</ArticleId></ArticleIdList></Reference><Reference><Citation>Foisy M M, Yakiwchuk E M, Chiu I et al.Adrenal suppression and Cushing&#x2019;s syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med. 2008;9:389&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">18459946</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias SS G, Soares V C, Ferreira A C et al.Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog. 2020;16:e1009127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773323</ArticleId><ArticleId IdType="pubmed">33326472</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Li W, Hui H et al.Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J. 2020;39:e106057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537045</ArticleId><ArticleId IdType="pubmed">32944968</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanczkowski W, Evert K, Stadtmuller M et al.COVID-19 targets human adrenal glands. Lancet Diabetes Endocrinol. 2022;10:13&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8601687</ArticleId><ArticleId IdType="pubmed">34801110</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, Schwarz PE H, Perakakis N et al.The interface of COVID-19, diabetes, and depression. Discover Mental Health. 2022;2:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8886346</ArticleId><ArticleId IdType="pubmed">35253006</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen D G et al.Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;INF.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo A C, Davanzo G G, Monteiro L B et al.Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1alpha/glycolysis-dependent axis. Cell Metab. 2020;32:437&#x2013;446 e435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7367032</ArticleId><ArticleId IdType="pubmed">32697943</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal J, Ghosh A, Bhatt S P et al.High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: a case-control study. Diabetes Metab Syndr. 2021;15:102302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462068</ArticleId><ArticleId IdType="pubmed">34626924</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Guijarro C, Torres-Macho J et al.Diabetes and the risk of long-term post-COVID symptoms. Diabetes. 2021;70:2917&#x2013;2921.</Citation><ArticleIdList><ArticleId IdType="pubmed">34580087</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, Ben Nasr M, D&#x2019;Addio F et al.Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3:774&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Anton M C, Sivakumar T. New-onset diabetes in &#x201c;long COVID&#x201d;. J Diabetes. 2021;13:693&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251301</ArticleId><ArticleId IdType="pubmed">33893710</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrigpuri P, Sonal S, Spalgais S et al.Uncontrolled diabetes mellitus: A risk factor for post COVID fibrosis. Monaldi Arch Chest Dis. 2021:91. doi: 10.4081/monaldi.2021.1607.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2021.1607</ArticleId><ArticleId IdType="pubmed">33501821</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A V, Misra A. Post COVID-19 Syndrome (&#x201c;Long COVID&#x201d;) and diabetes: challenges in diagnosis and management. Diabetes Metab Syndr. 2021;15:102235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller L, Berber E, Sumbria D et al.Controlling the burden of COVID-19 by manipulating host metabolism. Viral Immunol. 2022;35:24&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863913</ArticleId><ArticleId IdType="pubmed">34905407</ArticleId></ArticleIdList></Reference><Reference><Citation>Cengiz M, Borku Uysal B, Ikitimur H et al.Effect of oral l-glutamine supplementation on Covid-19 treatment. Clin Nutr Exp. 2020;33:24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387270</ArticleId><ArticleId IdType="pubmed">32835086</ArticleId></ArticleIdList></Reference><Reference><Citation>Eroglu I, Eroglu B C, Guven G S. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19) Nutrition. 2021;90:111308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8087860</ArticleId><ArticleId IdType="pubmed">34111831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler N G, Gray N, Kimhofer T et al.Systemic perturbations in amine and kynurenine metabolism associated with acute SARS-CoV-2 infection and inflammatory cytokine responses. J Proteome Res. 2021;20:2796&#x2013;2811.</Citation><ArticleIdList><ArticleId IdType="pubmed">33724837</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T, Yoshinaga S K, Shibue K et al.Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19. Cell Death Differ. 2021;28:3199&#x2013;3213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522258</ArticleId><ArticleId IdType="pubmed">34663907</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Reisz J A et al.COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5 doi: 10.1172/jci.insight.140327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Julius U, Tselmin S, Schatz U et al.Actual situation of lipoprotein apheresis in patients with elevated lipoprotein (a) levels. Atheroscler Suppl. 2019;40:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31818437</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S R, Voit-Bak K, Donate T et al.Chronic post-COVID-19 syndrome and chronic fatigue syndrome: is there a role for extracorporeal apheresis? Mol Psychiatry. 2022;22:34&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209771</ArticleId><ArticleId IdType="pubmed">34140635</ArticleId></ArticleIdList></Reference><Reference><Citation>Morawietz H, Julius U, Bornstein S R. Cardiovascular diseases, lipid-lowering therapies and European registries in the COVID-19 pandemic. Cardiovasc Res. 2020;116:e122&#x2013;e125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454396</ArticleId><ArticleId IdType="pubmed">32678443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>